‘BIO USA 2025’ Company Presentation

Selected for the 2025 Startup Growth Technology Leap Program (Ministry of SMEs and Startups)

Registered a patent for GXC301, a therapeutic agent for Lafora disease

ASGCT 28th Annual Meeting Abstracts, ‘AI-guided Vector Engineering for Enhanced ALS Therapy’

Published a paper on AAV delivery efficiency in IBRO Neuroscience

BIONNOVA Leaders Forum & Expo 2025 – Invited speaker

Gyeonggi -Do Governor’s Commendation for ‘Startup Founding & Job Creation’

Filed a patent of Virus Amino Acid Sequence Derivation System and Method

funded by a government R&D program by Ministry of SMEs and Startups

Presented ‘Engineering Next-Generation AAV Vectors for Enhanced ALS Therapy’ at SfN 2024 (Society for Neuroscience Meetings)

Awarded at ‘G-Star Audition Scale-Up’ Global Startup IR Competition

Filed a patent of CNS-specific peptides & AAV variants

Signed a MOU with Modalis Therapeutics Corporation, jointly developing a XOB031-mediated AAV gene therapy for Alzheimer’s disease

ODD request of GXC-301, a therapeutic agent for Lafora disease, granted by US FDA

Selected as a ‘2024 UNICORN’ and raised UDS 2M (Global Unicorn Project by Ministry of SMEs and Startups)

RPDD request of GXC-301, a therapeutic agent for Lafora disease, granted by US FDA

InsightMiner™, won a prize and a award at AI Rocket Launcher Day Season4, 2024 AI EXPO

A ‘co-developing’ Alzheimer’s disease therapeutic program with Hanyang Univ., funded by a governmental global R&D program from KHIDI

MOU signed with AJOU MBD T2B Center

Change of corporate name to GENIXCURE Inc.

Filed 4 patents of AI-based cell-specific peptides & AAVs (featuring 60 vectors)

Made a presentation of GXC-301(Lafora disease) preclinical data at 2023 Lafora Disease Science Symposium in Bologna, Italy

Filed a patent application for GXC301, a therapeutic agent for Lafora disease

Made a presentation of an AAV program at ISCT 2023 in Paris (Collaborative research with Samsung Seoul Hospital)

Signed MOUs with Kyungdong Pharmaceutical Co., Ltd. for GMP CDMO and L/O

Signed Research and Development Agreement with ToolGen

Inno-Biz Certification (Minister of Small and Medium Venture Business)

Participation in R&D projects to foster research-oriented hospitals (supervisor: Samsung Seoul Hospital)

Series A fundraising

TF launched for InsightMiner™ 1.0

Signed a MOU with MedySapiens

funded by a government R&D program by KHIDI

GXC301 funded by a government R&D program by Ministry of SMEs and Startups

Awarded ‘Appreciation of Technology Commercialization & Entrepreneurship’ from Ministry of Health and Welfare

funded 1M by a government R&D program by Ministry of Health and Welfare

Certification of venture companies

Certification of corporate research institutes

Founded